Giant cell tumor tendon sheath
Also known as: Fibroid, Leiomyoma, Fibrous, Tumor
Methodology & AI Transparency ⓘ
Giant cell tumor tendon sheath Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as M65.88, Giant cell tumor tendon sheath (also termed Fibroid or Leiomyoma) falls under Cancer & Oncology management, where immunohistochemistry [Giant cell tumor tendon sheath M65.88] establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Diagnostic registry M65.88: Giant cell tumor tendon sheath is managed within Cancer & Oncology (aka Fibroid).
- 3 Typical cash cost range: Primary evaluation for Giant cell tumor tendon sheath incorporates immunohistochemistry [Giant cell tumor tendon sheath M65.88] and symptom diary review.
- 4 Top reported side effects / signs: Key Cancer & Oncology biomarkers for Giant cell tumor tendon sheath (M65.88): Pathology / Molecular in Giant cell tumor tendon sheath (M65.88: Genomic Staging) & Complete Blood Count in Giant cell tumor tendon sheath (M65.88: (ANC, Hemoglobin, Platelets)) (Safe hematologic reserve (M65.88)).
Ask our AI Specialists anything about Giant cell tumor tendon sheath
What Is Giant cell tumor tendon sheath?
Designated in federal medical registries as M65.88, Giant cell tumor tendon sheath (also termed Fibroid or Leiomyoma) falls under Cancer & Oncology management, where immunohistochemistry [Giant cell tumor tendon sheath M65.88] establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Giant cell tumor tendon sheath (M65.88, Cancer & Oncology) reflects microenvironment inflammation [Giant cell tumor tendon sheath M65.88]. longitudinal control is benchmarked via Pathology / Molecular in Giant cell tumor tendon sheath (M65.88: Genomic Staging).
Common Symptoms & Clinical Signs
- • Presentation of Giant cell tumor tendon sheath (M65.88): persistent painless lump, in Giant cell tumor tendon sheath (M65.88: non-healing ulcer/mole change,)
- • Secondary Giant cell tumor tendon sheath clinical sign: unintended weight loss [Giant cell tumor tendon sheath M65.88]
- • Symptom flares in Giant cell tumor tendon sheath correlating with Pathology / Molecular in Giant cell tumor tendon sheath (M65.88: Genomic Staging) deviation outside Guideline-concordant surveillance (M65.88)
- • Functional cancer & oncology impact requiring immunohistochemistry [Giant cell tumor tendon sheath M65.88] evaluation (M65.88)
Giant cell tumor tendon sheath Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M65.88 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Cancer, Oncology & Supportive Care | NLM Clinical Tables |
| Diagnostic / Lab Marker: Pathology / Molecular in Giant cell tumor tendon sheath (M65.88: Genomic Staging) | Guideline-concordant surveillance (M65.88) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Complete Blood Count in Giant cell tumor tendon sheath (M65.88: (ANC, Hemoglobin, Platelets)) | Safe hematologic reserve (M65.88) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Comprehensive Metabolic & in Giant cell tumor tendon sheath (M65.88: Organ Function Panel) | Preserved renal/hepatic clearance (M65.88) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Giant cell tumor tendon sheath
Treatment selection for Giant cell tumor tendon sheath depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Giant cell tumor tendon sheath)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Four months of treatment with anakinra combined with glucocorticoids for giant Although prematurely discontinued, this study does not support the use of 4 months of treatment with anakinra combined with GCs to reduce the risk of relapse or GC exposure. Arthritis research & therapy • 2025-06-07 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40483523 ↗ |
| Can This Approach Help? Inside the Latest Research on Pexidartinib improves physical functioning and stiffness in patients with Patients receiving pexidartinib had higher response rates than patients receiving placebo for meaningful improvements in physical function and stiffness. Acta orthopaedica • 2021-08-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 33977825 ↗ |
| Can This Approach Help? Inside the Latest Research on A phase 3 randomized, gold-standard blind, compared against a dummy pill Owing to the small sample size due to the early termination, it is difficult to draw clear conclusions from this study. Arthritis research & therapy • 2023-10-16 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 37840134 ↗ |
| Can This Approach Help? Inside the Latest Research on Mixed-Methods to Define Meaningful Change using Exit Interviewand Clinical Trial The responder definitions were at least a 3-point improvement for PROMIS-PF, a 10% improvement for active ROM, and a 2-point improvement for the Worst Stiffness NRS. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation • 2026-02-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41621028 ↗ |
| Can This Approach Help? Inside the Latest Research on Secukinumab for Giant Cell Sustained full symptom relief at week 52 did not differ significantly between patients with GCA randomly assigned to receive SEC-300 with a 26-week GC taper versus placebo with a 52-week GC taper. NEJM evidence • 2026-07-15 • Phase III Randomized Trial | N = 140 | 88/100 | PMID 42234457 ↗ |
Giant cell tumor tendon sheath Patient Community & “People Like Me” Threads
Filter Giant cell tumor tendon sheath community threads and patient logs by age, biological sex, dosage, and treatment duration.